Bridgewater Associates’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $132M | Buy |
|
|||||
|
2025
Q2 | $46.7M | Buy |
|
|||||
|
2025
Q1 | $13.3M | Buy |
|
|||||
|
2024
Q4 | $206K | Sell |
|
|||||
|
2024
Q3 | $586K | Sell |
|
|||||
|
2024
Q2 | $5.63M | Sell |
|
|||||
|
2024
Q1 | $58.9M | Sell |
|
|||||
|
2023
Q4 | $96.7M | Buy |
|
|||||
|
2023
Q3 | $50M | Sell |
|
|||||
|
2023
Q2 | $72.5M | Buy |
|
|||||
|
2023
Q1 | $53.3M | Buy |
|
|||||
|
2022
Q4 | $28.1M | Sell |
|
|||||
|
2022
Q3 | $39.6M | Sell |
|
|||||
|
2022
Q2 | $43.7M | Buy |
|
|||||
|
2022
Q1 | $3.81M | Sell |
|
|||||
|
2021
Q4 | $4.76M | Buy |
|
|||||
|
2021
Q3 | $4.49M | Sell |
|
|||||
|
2021
Q2 | $7.08M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $17.1M | Buy |
|
|||||
|
2019
Q2 | $743K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $1.81M | Sell |
|
|||||
|
2018
Q3 | $5.16M | Buy |
|
|||||
|
2018
Q2 | $3.97M | Sell |
|
|||||
|
2018
Q1 | $7.53M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $11.5M | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $324K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $837K | Buy |
|
|||||
|
2015
Q2 | $408K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $4.84M | Buy |
|
|||||
|
2014
Q3 | $577K | Sell |
|
|||||
|
2014
Q2 | $5.2M | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $922K | Buy |
|